Early Phase Drug Evaluation in ManJohn O'Grady, Otto I Linet CRC Press, 2020 M02 3 - 737 pages Early Phase Drug Evaluation in Man is a comprehensive, practical guide that covers pre-clinical information relevant to early human studies, including pharmaceutical, metabolic, toxicological, and regulatory aspects, as well as the general considerations relevant to all early human studies. Each major therapeutic area is considered by class of activity of drug. The chapters describe what measurements of drug activity are available in healthy human subjects and in patients, how to make the measurements, their value and their limitations. The contributors have been drawn internationally from the pharmaceutical industry and academia. Early Phase Drug Evaluation in Man will provide an important reference guide for industry and academic professionals involved in the development of new drugs. |
From inside the book
Results 1-5 of 95
Page v
... Assurance B. Gennery 127 III . Ethical and Legal Considerations 137 12 . Ethical Aspects of Research in Healthy Volunteers S. J. Warrington 139 13. Ethical Aspects of Research in Patients F. Wells 14. Contents Table of Contents.
... Assurance B. Gennery 127 III . Ethical and Legal Considerations 137 12 . Ethical Aspects of Research in Healthy Volunteers S. J. Warrington 139 13. Ethical Aspects of Research in Patients F. Wells 14. Contents Table of Contents.
Page 3
... considerations in the design and development of all dosage forms or drug delivery systems for all routes of administration is beyond the scope of this chapter . An overview of critical pharmaceutical considerations for dosage forms ...
... considerations in the design and development of all dosage forms or drug delivery systems for all routes of administration is beyond the scope of this chapter . An overview of critical pharmaceutical considerations for dosage forms ...
Page 4
... CONSIDERATIONS The development process usually begins with preformulation characterisation of drug substance ... consideration of biochemical and transcellular events at the cellular level is important . Table 1.1 Preformulation ...
... CONSIDERATIONS The development process usually begins with preformulation characterisation of drug substance ... consideration of biochemical and transcellular events at the cellular level is important . Table 1.1 Preformulation ...
Page 6
... CONSIDERATIONS A review of pharmaceutical dosage forms available in most major markets around the globe would indicate that tablets and capsules are by far the most widely used dosage form , primarily because of advances in the ...
... CONSIDERATIONS A review of pharmaceutical dosage forms available in most major markets around the globe would indicate that tablets and capsules are by far the most widely used dosage form , primarily because of advances in the ...
Page 7
... considerations Tablets : compressed layered sugar - coated film - coated enteric - coated chewable controlled - release sublingual buccal effervescent Hard - filled capsules Soft gelatin capsules Suppositories Emulsions Gels / creams ...
... considerations Tablets : compressed layered sugar - coated film - coated enteric - coated chewable controlled - release sublingual buccal effervescent Hard - filled capsules Soft gelatin capsules Suppositories Emulsions Gels / creams ...
Contents
Organisation and Decision Making | 97 |
Ethical and Legal Considerations | 137 |
Measuring Drug Activity in Man | 193 |
Assessment of Drug Effects on the Cardiovascular System ... | 251 |
Assessment of Drug Effects on the Respiratory System ... | 349 |
Assessment of Drug Effects on the Central Nervous System ... | 377 |
Assessment of Drug Effects on the Gastrointestinal System ... | 455 |
Assessment of Drug Effects on the Kidney | 493 |
Assessment of the Effects of Drugs Used in Obstetrics and Gynaecology ... | 519 |
Assessment of Drug Activity in the Skin | 551 |
Assessment of Drugs Used for the Treatment of Metabolic Disorders ... | 599 |
Assessment of the Effects of Chemotherapeutic Agents ... | 625 |
Assessment of Drugs Affecting the Inflammatory Process and Pain ... | 655 |
Index | 703 |
Other editions - View all
Common terms and phrases
absorption acid action activity acute administration adverse agents analgesic animal antidepressant anxiety anxiolytic assay assessment asthma benzodiazepines bioavailability biological blood pressure cardiac output cells changes chronic Clin clinical research clinical trials compound concentration consent coronary corticosteroids determine disease diuretics dosage dose drug development duration eczema effects of drugs efficacy enantiomers enzyme ethics committee evaluation excretion exercise experimental factors function gastric gastrointestinal gastrointestinal tract glucose guidelines healthy volunteers heart human important increase induced inhibition insulin intravenous investigator laboratory levels measurement metabolism metabolites method minoxidil monitoring myocardial normal NSAIDs oral pain parameters patients performed Pharm pharmaceutical pharmacodynamic pharmacokinetic pharmacological placebo plasma platelet potential preclinical predictive produce prostaglandin protocol receptor regulatory renal response rheumatoid arthritis risk safety scales Shuster side-effects skin specific studies subjects symptoms techniques therapeutic therapy tion tolerance toxicology treatment urine uterine visual analogue scales vitro vivo